Corporate Profile

Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease.

The company’s Orbital Atherectomy Systems treat calcified and fibrotic plaque in arterial vessels throughout the leg and heart in a few minutes of treatment time, and address many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives.

The U.S. FDA granted 510(k) clearance for the use of the Diamondback Orbital... More >>

Recent News

More >>
Cardiovascular Systems to Webcast Fiscal 2018 First-Quarter Earnings Conference Call Wednesday, October 25 10/04/17
Live Webcast at 3:45 p.m. CT (4:45 p.m. ET) Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII) will host a live webcast of its fiscal 2018 first-quarter conference call on Wednesday, October 25, 2017, at 3:45 p.m. CT (4:45 p.m. ET). Scott Ward, Chairman, President and Chief Executive Officer, and Larry Betterley, Chief Financial Officer, will discuss CSI’s results for its fiscal first quarter ended September 30, 2017, and its financial outlook. The company will issue a post-market earnings release prior to the call on October 25. To access the live webcast, go to the events section of the company’s investor relations website, , on the day of the conference call and click on the webcast link. A webcast replay will be available beginning at 6:45 p.m. CT the same day. To participate in the conference call, dial (833) 241-7255 and enter 95692520. Please dial in at least 10 minutes prior to the call. About Cardiovascular Systems, Inc. ...
More >>
Cardiovascular Systems Announces Anticipated Revenue Impact from Hurricanes Harvey and Irma 09/18/17
Cardiovascular Systems, Inc. (CSI) (NASDAQ:CSII) today said that the impact of Hurricanes Harvey and Irma on procedure volumes in the greater Houston area and throughout Florida will reduce fiscal 2018 first-quarter revenues. “Our thoughts go out to our employees in Florida and Texas and others affected by Hurricanes Harvey and Irma,” said Scott Ward, CSI’s Chairman, President and Chief Executive Officer. “As recovery progresses, we will closely monitor conditions and the anticipated impact on our business. While these historic storms are affecting our near-term performance, they are not indicative of our long-term growth opportunity and continued market leadership position.” The potential revenue impact on CSI quarterly results is magnified due to the company’s small product portfolio and the location and timing of the storms. The Houston and Florida markets typically generate over 15% of CSI’s revenues. In addition, fiscal first quarter revenues are more heavily weighted in...
More >>